US judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk
AI Summary
A US judge declined to block Eli Lilly advertisements for its weight-loss drug in a dispute brought by Novo Nordisk. The ruling is a legal and commercial development involving competing pharmaceutical companies.